Articles

Characterization of leukemias with ETV6-ABL1 fusion

CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Centro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy
Pediatric Hematology and Oncology, Hannover Medical School, Germany
University of New Mexico Cancer Center, Albuquerque, NM, USA
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA
South Australia Health and Medical Research Institute, Adelaide, Australia
Department of Pediatrics, Hematology-Oncology, Benioff Children’s Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
University of New Mexico Cancer Center, Albuquerque, NM, USA
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Department of Haematology, Our Lady’s Children’s Hospital, Dublin, Ireland
Department of Cancer Biology, Institut Paoli Calmettes, Marseille, France
Department of Hematology, Institut Paoli Calmettes, Marseille, France
Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Department of Hematology, Leiden University Medical Center, The Netherlands
Birmingham Children’s Hospital, NHS Foundation Trust, UK
Department of Cytogenetics, Leicester Royal Infirmary NHS Trust, UK
St. Anna Children’s Hospital, Childrens Cancer Research Institute, Vienna, Austria
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Department of Pediatrics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, PA, USA
South Australia Health and Medical Research Institute, Adelaide, Australia
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA
University of New Mexico Cancer Center, Albuquerque, NM, USA
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Vol. 101 No. 9 (2016): September, 2016 https://doi.org/10.3324/haematol.2016.144345